G. Buchappa, P. S. Vijay Kumar, K. D. Prasad, and P. Aparna, “Scalable and Impurity-Free Process for Dasatinib: Src and BCR-Abl Inhibitor”, ajc, vol. 30, no. 7, pp. 1621–1628, May 2018.